# Agricultural Biologicals Market

> Agricultural Biologicals Market Research Report Information By Function (Crop Nutrition, Crop Protection), By Crop Type (Row Crops, Horticultural Crops, Cash Crops), By Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) - Forecast to 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 10.18%
- **2025:** USD 32.15 Billion
- **2035:** USD 80.47 Billion
- **Key Players:** BASF SE, Bayer AG, Corteva Agriscience, Syngenta Group, UPL Ltd., FMC Corporation, Novozymes (now Novonesis), Marrone Bio Innovations

**Report ID:** MRFR/Agri/5166-CR · **Pages:** 200 · **Author:** Snehal Singh · **Last Updated:** July 20, 2026

**URL:** https://www.marketresearchfuture.com/reports/agricultural-biologicals-market-6629

---

## Market Summary

As per Market Research Future Analysis, Agricultural Biologicals Market Size was valued at USD 11,505.69 million in 2024. The Agricultural Biologicals Industry is projected to grow from USD 13,070.46 million in 2025 to USD 45,797.33 million by 2035, exhibiting a compound annual growth rate (CAGR) of 13.6% during the forecast period 2025 - 2035.

## Market Drivers

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Tightening MRL regulations on chemical residues | ~18% | EU, Japan, South Korea | Short-term (≤2 yr) | [2] |
| Organic farmland expansion worldwide | ~16% | Global | Medium-term (2–4 yr) | [3] |
| Streamlined biological product registration | ~14% | US, Brazil, India | Medium-term (2–4 yr) | [8] |
| Retailer residue-free sourcing mandates | ~12% | North America, EU | Short-term (≤2 yr) | [13] |
| Advances in microbial fermentation technology | ~11% | Global | Long-term (≥4 yr) | [12] |
| Precision agriculture and digital integration | ~10% | North America, Asia-Pacific | Long-term (≥4 yr) | [10] |
| Government subsidy programs for biological inputs | ~9% | India, Brazil, China | Medium-term (2–4 yr) | [9] |

### Tightening Maximum Residue Limits

The European Union’s ongoing updates to its maximum residue limit frameworks have systematically lowered permissible residue thresholds on multiple active chemical substances, directly restricting conventional pesticide use on export-destined produce. Concurrently, Japan’s established Positive List System enforces strict pesticide residue limits on agricultural imports. These strict regulatory walls act as a primary near-term catalyst for the Agricultural Biologicals Market, forcing global exporters to rapidly adopt biofungicide crop protection alternatives to preserve vital international market access, particularly across high-value horticultural export supply chains.

### Global Organic Acreage Expansion

Certified organic farmland has demonstrated steady, multi-year expansion worldwide, anchored by high double-digit percentage increases in production footprints over the last few seasons. Domestically, the USDA’s organic certification continues to absorb substantial acreage. In contrast, the European Union’s organic action plan sets aggressive target benchmarks to transition a massive share of total continental farmland under organic management by the end of the decade. This structural acreage shift directly enlarges the addressable base for [biostimulant](https://www.marketresearchfuture.com/reports/biostimulants-market-2770) plant health inputs and biological soil treatment products, as organic standards prohibit the vast majority of synthetic alternatives.

### Retailer-Led Sustainability Mandates

Major global food retail groups have instituted progressive corporate ESG parameters and integrated pest management requirements that mandate residue-free or residue-reduced sourcing across fresh produce supply chains. These private-sector mandates ripple directly upstream, compelling growers and distributors to integrate bioinsecticide and biopesticide solutions into their management protocols regardless of minimum government standards. The commercial pull from retail sustainability programs reinforces consistent volume demand for sustainable biological agriculture practices, functioning independently of state-level regulation.

## Restraints

The restraint impacts below reflect directional headwinds that moderate the Agricultural Biologicals Market CAGR. These are not additive deductions from growth rates but represent relative friction coefficients within the demand environment.

| Restraint | ~% Negative Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Cold-chain logistics dependence | ~–20% | Emerging markets, Africa | Short-term (≤2 yr) | [14] |
| Feedstock and fermentation cost volatility | ~–18% | Global | Medium-term (2–4 yr) | [15] |
| Inconsistent field efficacy perceptions | ~–15% | North America, Asia-Pacific | Long-term (≥4 yr) | [16] |
| Limited shelf-life of microbial products | ~–12% | Tropical regions | Short-term (≤2 yr) | [14] |
| Fragmented regulatory standards across markets | ~–10% | Global | Long-term (≥4 yr) | [17] |

### Cold-Chain Logistics and Shelf-Life Constraints

Maintaining an unbroken refrigerated distribution network presents a significant structural challenge for living, microbial-based biological formulations. Because these sensitive biological products often require strict temperature controls to keep active colony-forming units viable, a lack of deep regional cold-chain infrastructure across emerging markets severely limits the penetration of premium biofungicides. This logistical bottleneck increases last-mile distribution complexity and overhead costs relative to highly stable synthetic alternatives, restricting market growth within developing agricultural economies.

### Feedstock and Fermentation Cost Volatility

The production economics of industrial biopesticides are closely tied to global commodity markets due to their heavy reliance on agricultural fermentation media like soy extracts and molasses. When the market costs of these unrefined carbon substrates experience sharp pricing spikes, biological manufacturers must either accept tighter profit margins or pass raw material expenses directly to end-users. This commercial pressure slows down product adoption among price-sensitive smallholder farmers, highlighting the need for waste-stream valorization.

### Field Efficacy Perception Gaps

While rigorous experimental trials often demonstrate impressive peak pest suppression capabilities for advanced bioinsecticides, real-world on-farm performance regularly fluctuates. Local environmental variables, including baseline ultraviolet exposure, shifting ambient temperature ranges, and complex native soil microbiome interactions, can significantly reduce field-level consistency. This performance variance maintains historical grower skepticism across commodity-crop regions. Overcoming this trust deficit requires expanded investments in localized agricultural extension networks and digital decision-support agronomy tools.

## Opportunities

### Precision Biologicals and Digital Agronomy Integration

Pairing digital agronomy tools with agricultural biologicals allows modern growers to reduce field efficacy variability significantly. Utilizing real-time [soil moisture monitoring](https://www.marketresearchfuture.com/reports/soil-monitoring-market-11070), microbiome sequencing, and sensor-guided variable-rate application systems allows crop managers to execute highly optimized input dosing schedules. This precise technical synergy ensures that specialized biostimulants are delivered exactly when and where crop roots require them, maximizing localized plant health outcomes and accelerating commercial adoption among large-scale, tech-forward farming operations.

### RNA-Based Next-Generation Biopesticides

Next-generation RNA interference technology represents a transformative milestone for highly targeted pest management. This advanced bio-input mechanism utilizes sequence-specific molecules to disrupt vital functions in designated target pests while maintaining near-zero toxicity for beneficial insects and surrounding ecosystems. Following landmark international regulatory approvals for sprayable RNA-based active ingredients, major crop protection conglomerates are actively scaling up commercial manufacturing pipelines to embed these highly precise, low-residue formulations into mainstream integrated pest management frameworks.

### Emerging Market Subsidy Expansion

State-backed credit incentives and farming subsidies are rapidly accelerating the adoption of organic biofertilizers across emerging agricultural economies. National structural programs, including Brazil’s targeted environmental credit lines and India's ongoing chemical-free cultivation initiatives, are systematically reducing upfront cost barriers for medium-scale rural producers. These strategic government interventions provide highly accessible entry options for international biological manufacturers, allowing them to rapidly scale up regional distribution pipelines across expanding, high-volume agricultural territories.

### Biological Data Monetization and Subscription Models

Biological crop protection manufacturers are actively pioneering service-oriented subscription models to secure more consistent commercial revenue streams. These customized packages bundle advanced bio-inputs directly with structural agronomic advisory services, predictive soil health diagnostics, and digital yield tracking software. This integrated commercial framework significantly improves multi-season customer retention rates. Concurrently, the operational model builds highly specialized field-performance databases, allowing companies to refine product application guidelines and improve overall predictability across diverse crop microclimates.

## Future Outlook

### AI-Driven Precision Biological Application

Artificial intelligence is steadily improving how advanced biological inputs are deployed across commercial farming systems. Machine-learning algorithms process high-resolution satellite imagery, multi-season weather patterns, and localized soil health metrics to help agronomists optimize target application rates. By transitioning away from uniform field spraying to data-driven, variable-rate distribution methods, crop managers can minimize unnecessary product waste. This technical alignment improves the real-world field efficacy of delicate biostimulant formulations while boosting overall plant health outcomes.

### Fermentation Technology Scale-Up

Recent innovations in continuous fermentation systems and solid-state bioprocessing are progressively optimizing the production economics of microbial biopesticides. By investing in modular, containerized fermentation units, input manufacturers can establish localized production hubs directly inside core agricultural regions. This distributed processing strategy effectively bypasses the complex cold-chain logistics constraints that have historically limited the shelf life and regional penetration of living biological soil treatments throughout tropical climates and distant emerging markets.

### ESG Reporting and Carbon Credit Integration

The mandatory inclusion of agriculture within Scope 3 corporate emissions accounting is driving significant new demand for traceable bio-input usage metrics. Farmers utilizing target biostimulant and biofungicide programs can formally document their reduced reliance on synthetic fertilizers under validated carbon credit protocols, including Verra’s VM0042 framework. This integration allows agricultural operations to secure verified environmental assets, directly benefiting from multi-national corporate supply-chain decarbonization mandates focused on building net-zero food systems.

## Segment Insights

### By Function

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Crop Nutrition | 69% revenue share (2025) | Biostimulant plant health adoption in row crops |
| Crop Protection | 10.3% CAGR (2026–2035) | Bioinsecticide, biopesticide and biofungicide crop protection registrations |

The Agricultural Biologicals Market is anchored by crop nutrition, which encompasses biostimulants, biofertilizers, and soil amendments. Biostimulant plant health products — particularly seaweed extracts, humic acids, and microbial inoculants — have moved from premium niche positioning to mainstream agronomic recommendations across corn, soybean, and wheat production. Growers report yield improvements of 5–12% when integrating biostimulants into conventional fertilization programs [5].

Crop protection is the fastest-expanding function as regulatory pressure restricts chemical alternatives. Bioinsecticide biopesticide formulations based on Bacillus thuringiensis (Bt) and Beauveria bassiana have achieved efficacy levels comparable to synthetic counterparts in controlled field trials. Biofungicide crop protection products targeting soil-borne pathogens like Fusarium and Rhizoctonia are gaining traction in high-value vegetable and fruit production. The Agricultural Biologicals Market for crop protection is also being propelled by RNA interference technologies entering late-stage development [12].

### By Crop Type

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Row Crops | USD 22.50 Billion (2025) | Corn, soybean, and wheat biological soil treatment programs |
| Horticultural Crops | 10.9% CAGR (2026–2035) | Residue-free export mandates for fruits and vegetables |
| Cash Crops | 9.4% CAGR (2026–2035) | Coffee, cocoa, and cotton sustainable biological agriculture certifications |

Row crops dominate volume demand within the Agricultural Biologicals Market, given the sheer acreage of corn, soybeans, wheat, and rice treated annually. Biological soil treatment products — particularly seed-applied microbial inoculants — have become standard practice on over 60% of US soybean acres [8]. Horticultural crops are expanding fastest as export-driven quality requirements compel growers to adopt biofungicide crop protection and bioinsecticide and biopesticide solutions that meet importing-country MRL thresholds.

## Regional Market Share Analysis

| Region | Key Metric | Primary Investment Themes |
| --- | --- | --- |
| North America | 12.7% CAGR (2026–2035) | EPA biologicals fast-track, retailer mandates, biostimulant plant health |
| Europe | 37% revenue share (2025) | Farm to Fork compliance, MRL tightening and sustainable biological agriculture |
| Asia-Pacific | USD 8.36 Billion (2025) | Government subsidies, rice paddy biologicals and biological soil treatment |
| South America | 10.5% CAGR (2026–2035) | Soybean/corn bioinsecticide biopesticide adoption, ABC+ Plan financing |
| Middle East & Africa | USD 1.61 Billion (2025) | Arid-climate biostimulants, donor-funded soil health programs |
| Total | USD 32.15 Billion (2025) | — |

The Agricultural Biologicals Market spans diverse regulatory and agronomic environments, with regional adoption patterns shaped by policy frameworks, farming system structure, and export market requirements.

### North America

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| US | 78% of regional revenue (2025) | State-level pesticide restrictions, bioinsecticide and biopesticide registrations |
| Canada | 10.8% CAGR (2026–2035) | Canola and pulse crop biological treatments |
| Mexico | USD 0.58 Billion (2025) | Export-oriented berry and avocado biofungicide crop protection |

The US accounts for the vast majority of North American demand, supported by the EPA's streamlined biopesticide registration and major retailer sustainability programs. California's Department of Pesticide Regulation has accelerated biological product approvals by 40% since 2023, while Midwest corn belt growers are integrating biological soil treatment into regenerative agriculture rotations at a pace that has tripled since 2021 [8].

### Europe

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Germany | USD 2.15 Billion (2025) | National Action Plan on Sustainable Use of Pesticides |
| France | 22% of regional revenue (2025) | Ecophyto II+ program, biostimulant plant health mandates |
| Spain | 11.4% CAGR (2026–2035) | Mediterranean horticulture export compliance |
| Italy | USD 1.25 Billion (2025) | Organic viticulture and fruit crop biologicals |
| UK | 10.2% CAGR (2026–2035) | Post-Brexit regulatory divergence favors biologicals |
| Nordic Countries | USD 0.62 Billion (2025) | Sustainable biological agriculture policy leadership |
| Russia | 9.1% CAGR (2026–2035) | Domestic bioinsecticide and biopesticide manufacturing expansion |
| Rest of Europe | USD 1.48 Billion (2025) | EU-wide MRL harmonization |

Europe's regulatory architecture makes it the natural stronghold for the Agricultural Biologicals Market. France's Ecophyto II+ program has reduced chemical phytosanitary product use by 20% since 2020, creating direct demand for biofungicide crop protection and biological soil treatment alternatives [2]. Spain's greenhouse-intensive horticulture sector in Almería and Murcia provinces has emerged as a high-growth corridor for biological inputs targeting export-grade residue-free tomatoes, peppers, and strawberries.

### Asia-Pacific

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| China | 32% of regional revenue (2025) | Zero-growth pesticide policy, microbial fertilizer mandates |
| India | 13.1% CAGR (2026–2035) | Biofertilizer subsidies, Paramparagat Krishi Vikas Yojana |
| Japan | USD 1.10 Billion (2025) | Positive List residue compliance, rice paddy biologicals |
| South Korea | 10.5% CAGR (2026–2035) | Smart-farm bioinsecticide biopesticide integration |
| ASEAN | USD 0.95 Billion (2025) | Export-oriented sustainable biological agriculture |
| Rest of Asia-Pacific | 9.8% CAGR (2026–2035) | Biostimulant plant health: emerging demand |

China's Ministry of Agriculture enforces a zero-growth policy on chemical fertilizers and pesticides that has redirected over USD 1.2 billion in R&D spending toward biological alternatives since 2020 [7]. India's biological input market is expanding rapidly under the Paramparagat Krishi Vikas Yojana (PKVY) organic farming scheme, which has enrolled over 4 million farmers and directly subsidizes biological soil treatment products.

### South America

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Brazil | 72% of regional revenue (2025) | Soybean nematode bioinsecticide biopesticide demand |
| Argentina | USD 0.68 Billion (2025) | Wheat and sunflower biostimulant plant health adoption |
| Rest of South America | 11.0% CAGR (2026–2035) | Expanding sustainable biological agriculture certifications |

Brazil is the Agricultural Biologicals Market powerhouse in South America. MAPA registered over 200 new biological products in 2024, and Brazilian soybean growers now apply biological nematicides on more than 40% of planted area [11]. The ABC+ Plan provides low-interest credit lines for producers adopting biological soil treatment and biostimulant plant health programs as part of climate-smart agriculture commitments.

### Middle East & Africa

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Saudi Arabia | 11.5% CAGR (2026–2035) | Vision 2030 food security, arid-climate biostimulants |
| UAE | USD 0.18 Billion (2025) | Controlled-environment agriculture biologicals |
| South Africa | 35% of regional revenue (2025) | Citrus and grape export biofungicide crop protection |
| Egypt | 10.8% CAGR (2026–2035) | Nile Delta soil health restoration programs |
| Rest of MEA | USD 0.52 Billion (2025) | Donor-funded biological soil treatment projects |

South Africa leads MEA demand, driven by stringent EU import MRL requirements on citrus and table grape exports. Saudi Arabia's Vision 2030 food security initiative is channeling investment into biostimulant plant health products suited for arid and saline soils, while Egypt's agricultural modernization programs along the Nile Delta increasingly incorporate sustainable biological agriculture practices [19].

## Competitive Benchmarking

The Agricultural Biologicals Market exhibits low concentration, with the top five players accounting for an estimated 28–34% of global revenue. The Herfindahl-Hirschman Index (HHI) sits below 600, reflecting a highly fragmented competitive field where specialty biological firms compete alongside diversified agrochemical multinationals. Strategic acquisitions have intensified since 2022, with legacy crop protection companies building dedicated biological divisions.

| Company | Est. Revenue Share Range | Key Offerings for the Agricultural Biologicals Market | Strategic Positioning |
| --- | --- | --- | --- |
| BASF SE | ~5–8% | Biostimulant plant health portfolio, Serifel biofungicide | Integrated chemical-biological crop solutions |
| Bayer AG | ~5–7% | Biological seed treatments, bioinsecticide, biopesticide pipeline | Crop science platform with digital integration |
| Corteva Agriscience | ~4–7% | Biologicals portfolio via Stoller acquisition, biostimulants | Row crop biological soil treatment focus |
| Syngenta Group | ~4–6% | Biofungicide crop protection, Valagro biostimulants | Sustainable biological agriculture innovation hub |
| UPL Ltd. | ~3–5% | NPP biological platform, bioinsecticide, biopesticide products | Emerging market distribution strength |
| FMC Corporation | ~3–5% | BioPhero pheromone technology, biological crop protection | Specialty biologicals differentiation |
| Novozymes (now Novonesis) | ~2–4% | Microbial inoculants, biostimulant plant health enzymes | Fermentation technology leadership |
| Marrone Bio Innovations | ~1–3% | Regalia biofungicide, Grandevo bioinsecticide | Pure-play biologicals innovator |
| Koppert Biological Systems | ~1–3% | Macro/micro-biological crop protection, pollination | Integrated pest management specialist |
| Valagro (Syngenta) | ~1–2% | Biostimulant plant health specialty products | Precision biostimulant formulations |

## Recent News & Developments

- Bayer AG (October 2024): Announced a USD 200 million investment in a dedicated biologicals manufacturing facility in Berkeley, California, scaling bioinsecticide and biopesticide fermentation capacity [22].
- [Syngenta Group](https://www.syngenta.com/products/biologicals) (August 2024): Received EU regulatory approval for three new biofungicide crop protection formulations under the Valagro brand, ahead of the 2025 growing season [6].
- US EPA (June 2024): Finalized revised registration guidelines reducing biopesticide review timelines to under 10 months, effective January 2025 [8].
- UPL Ltd. (April 2024): Entered a strategic partnership with Anuvia Life Sciences to develop enhanced-efficiency biological soil treatment products for Indian rice and wheat systems [9].
- Government of India (February 2024): Announced a 40% increase in biofertilizer and biopesticide subsidy allocations under the 2024–25 Union Budget, totaling INR 12,800 crore [9].
- FMC Corporation (2022) acquired BioPhero for nearly USD 200 million, adding pheromone-based bioinsecticide and biopesticide technology to its sustainable biological agriculture product line [23].

## Report Scope

| Parameter | Detail |
| --- | --- |
| Market Scope | Agricultural Biologicals Market — global, by Function, Crop Type, Geography |
| Study Period | 2021–2035 |
| CAGR (Forecast Period) | 10.18% (2026–2035) |
| Market Size (Base Year 2025) | USD 32.15 Billion |
| Market Size (2035) | USD 80.47 Billion |
| Fastest Growing Segments | Crop Protection (by Function); Horticultural Crops (by Crop Type); North America (by Region) |
| Companies Profiled | 10 (BASF, Bayer, Corteva, Syngenta, UPL, FMC, Novonesis, Marrone Bio, Koppert, Valagro) |
| Valuation Currency | USD Billion |

## Frequently Asked Questions

**Q: How do biological crop inputs compare to synthetic chemicals in cost per hectare for row crops?**
A: Biological inputs typically cost 10–20% more per hectare than synthetic equivalents. Still, total program costs often decrease because biologicals reduce the need for follow-up chemical applications and lower input waste through precision dosing [16]. Integrated programs combining both input types frequently deliver the highest return per hectare.

**Q: What cold-chain infrastructure investments are needed to scale biological distribution in tropical regions?**
A: Manufacturers are investing in lyophilized (freeze-dried) and encapsulated formulations that remain stable at ambient temperatures up to 35°C, reducing cold-chain dependency [14]. Modular, solar-powered cold storage units costing USD 15,000–25,000 per unit are also being deployed at regional distribution hubs across Sub-Saharan Africa.

**Q: Which Agricultural Biologicals Market segment offers the strongest margin profile for investors?**
A: Biostimulant plant health products command gross margins of 55–65%, significantly above the 35–45% range typical of commodity biofertilizers, because proprietary microbial strains and formulation technologies create defensible pricing power [5].

**Q: How does the Agricultural Biologicals Market address resistance management in pest populations?**
A: Biological pest control agents employ multi-modal mechanisms of action — parasitism, antibiosis, and competition — making single-target resistance development far less likely than with synthetic chemical actives [16]. Rotating biologicals with conventional inputs extends the useful life of both product categories.

**Q: What role does soil microbiome sequencing play in the Agricultural Biologicals Market?**
A: Soil microbiome diagnostics allow growers to match specific microbial inoculants to field-level deficiencies, improving biological soil treatment efficacy by 20–30% compared to blanket applications [10]. Sequencing costs have fallen below USD 50 per sample, making routine soil biological profiling economically viable for commercial-scale operations.

**Q: Are there specific Agricultural Biologicals Market entry barriers for small and mid-size manufacturers?**
A: Registration costs remain the primary barrier — obtaining multi-country biological product approvals can require USD 2–5 million and 3–5 years even under expedited pathways, which disproportionately burdens smaller innovators [17]. Strategic partnerships with established distributors help offset these costs.

**Q: How do carbon credit protocols value the adoption of biological inputs within the Agricultural Biologicals Market?**
A: Verra's VM0042 and similar soil carbon methodologies credit biological input adoption as a qualifying practice change, generating 0.3–0.8 carbon credits per hectare annually, depending on baseline soil conditions [20]. Revenue from credit sales can offset 15–25% of a grower's annual biological input expenditure.


## Sources

[2] Source: European Commission, "Farm to Fork Strategy: For a Fair, Healthy and Environmentally Friendly Food System," EC, 2024 (ec.europa.eu)
[5] Source: European Biostimulant Industry Council, "Market Overview: Biostimulants in Europe," EBIC, 2024 (biostimulants.eu)
[6] Source: BASF Agricultural Solutions, "Biological Solutions Product Pipeline Update," BASF, 2025 (agriculture.basf.com)
[7] Source: Chinese Ministry of Agriculture and Rural Affairs, "Zero-Growth Action Plan for Fertilizers and Pesticides," MARA, 2024 (www.moa.gov.cn)
[8] Source: US Environmental Protection Agency, "Revised Biopesticide Registration Guidelines," EPA, 2024 (www.epa.gov)
[9] Source: Government of India Ministry of Agriculture, "Union Budget 2025–26 Agricultural Allocations," MoA, 2025 (agricoop.nic.in)
[11] Source: Brazilian Ministry of Agriculture (MAPA), "Biological Product Registration Statistics," MAPA, 2024 (www.gov.br)
[12] Source: Nature Biotechnology, "RNA Interference-Based Crop Protection: Commercial Prospects," Nature, 2024 (www.nature.com)
[19] Source: Saudi Arabia Ministry of Environment, Water and Agriculture, "National Agriculture Strategy 2030," MEWA, 2024 (www.mewa.gov.sa)
[22] Source: Bayer CropScience, "Bayer Invests in Sacramento Biologicals Manufacturing Campus," Press Release, 2024 (www.bayer.com)
[23] Source: FMC Corporation, "FMC Acquires BioPhero to Expand Biological Portfolio," Press Release, 2023 (www.fmc.com)

---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/agricultural-biologicals-market-6629*